Health
Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma – News-Medical.Net
Chimeric Antigen Receptor T-cell therapy–CAR T–has revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors…
Chimeric Antigen Receptor T-cell therapy–CAR T–has revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors including childhood cancers such as neuroblastoma. Preclinical studies using certain CAR T against neuroblastoma revealed toxic effects.
Now, a group of scientists at Children’s Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting neuroblastoma, spares healthy brain tissue and more effectively…
-
Business23 hours agoThe ASX 200 returned 13.4% in FY25. Here’s how you could have got a slice
-
Noosa News23 hours agoFormer Brisbane Lions sponsor goes bust, leaving 200 workers in limbo
-
Noosa News22 hours agoHero rescuer reveals terrifying details of horror shark attack at Cabarita Beach in NSW
-
General22 hours agoSouth Australia Premier Peter Malinauskas under fire over awarding of golf course redesign contract to Greg Norman